Kailera Therapeutics Inc stock is traded at $12.17, with a volume of 845,960. It is down -4.92% in the last 24 hours and up +12.27% over the past month. Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
Previous Close:
$12.80
Open:
$13.30
24h Volume:
845,960
Relative Volume:
0.95
Market Cap:
$1.58B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-$0.6087
Net Cash Flow:
-
1W Performance:
-9.25%
1M Performance:
+12.27%
6M Performance:
-49.84%
1Y Performance:
0.00%
1-Day Range:
$11.88$13.30
1-Week Range:
$11.88$13.30
52-Week Range:
$9.76$28.23
Kailera Therapeutics Inc Stock (KLRA) Company Profile
Name
Kailera Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
508-440-9475Address
180 THIRD AVENUE, WALTHAM, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS